-
Lebanon says Hezbollah accepted US proposal to stop attacks
-
NBA Magic hire Spurs assistant Sweeney as new head coach
-
Huge NFL deals send Garrett to Rams, Brown to Patriots
-
Trump admin agrees to temporarily freeze 'slush fund' for allies
-
Mexican police tear-gas teachers' protest 10 days before World Cup
-
Berrettini back in French Open quarters after injury 'darkness'
-
Sabalenka bests Osaka at French Open, Berrettini into quarters
-
Sabalenka overpowers Osaka to reach French Open quarter-finals
-
Pro-Trump lawyer, leftist senator launch Colombia runoff campaigns
-
EU reaches deal on 'return hubs' migration reform
-
Lebanon's US embassy says Hezbollah accepted US proposal to stop attacks
-
Florida sues OpenAI, CEO Altman over ChatGPT harm to minors
-
Macron announces 93 bn euros in 'Choose France' foreign investments
-
Joshua says 'only success' matters as Fury fight looms
-
UN Security Council to meet on Lebanon war as Israeli forces push into south
-
UN agency blocks Trump official's appointment over US arrears
-
Trump says Israel, Hezbollah agree to halt fighting
-
Monaco sack coach Pocognoli
-
Auger-Aliassime gallops past Tabilo and into last eight
-
Sabalenka to face Osaka, Berrettini into French Open quarters
-
AI giant Anthropic confidentially files for IPO
-
'Resilient' Berrettini powers into French Open last eight
-
Colombia right-winger accused of 'stealing' national jersey
-
Still in the game: Athletes who made comeback in their 40s
-
Iran truce on the rocks as Guards threaten 'new fronts'
-
New York Times publisher slams AI companies' 'brazen theft' from news outlets
-
Rodri says Man City future can wait until after World Cup
-
Villarreal appoint Inigo Perez after Rayo success
-
Word nerds have a weekend on the tiles at Thailand's Scrabble title
-
Cobolli stops thinking and quells Svajda fightback at French Open
-
Czech court orders German neo-Nazi provocateur's extradition
-
French Open happy with Sabalenka-Osaka in top slot, but men still have edge
-
Serena Williams announces return to tennis at Queen's Club
-
Serena Williams to return to tennis at Queen's Club
-
Polish qualifier Chwalinska continues dream Roland Garros run
-
'We need to act now': Race to develop Ebola vaccine heats up
-
Iran truce on the rocks as Israel presses into Lebanon
-
Fans furious at Travis Scott's 20-minute Istanbul debut set
-
Two Syrians deny civil war torture accusations in Austria trial
-
Oil prices jump as Iran suspends peace talks
-
India takes down giant Messi statue over safety concerns
-
South Africa World Cup squad depart for Mexico following visa delay
-
Nvidia PC chip hailed as 'game changer' in race for AI device
-
'Stop killing women': Kenyans protest femicide scourge
-
Sabalenka to face Osaka, Cobolli into French Open quarters
-
Kevin Keegan reveals stage four cancer diagnosis
-
Cobolli fights into French Open last eight against dogged Svajda
-
Kalinskaya battles into French Open quarter-finals
-
Survey finds generational gap in attitudes to AI romance
-
Israel orders strikes on Beirut ahead of UN meeting
Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
DENVER, CO / ACCESS Newswire / June 1, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that it will be participating in a Fireside Q&A hosted by Lake Street Capital Markets at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub on Wednesday, June 17, 2026, at 10:30 a.m. Pacific time at the Bellagio Resort & Hotel.
To access the live webcast, please use the following information:
Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub
Date: Wednesday, June 17, 2026
Time: 10:30 a.m. Pacific time
Webcast: https://event.summitcast.com/view/bpjo3VVjZ25pp6SXpUua92/j8zQrjvPykncFs66WaA7AS
Management also will be conducting investor meetings at the conference on June 17-18. If you would like to schedule a 1x1 investor meeting with Aytu, and to attend the Planet MicroCap Las Vegas 2026 investor conference, please make sure you are registered here: REGISTER. Meetings will be scheduled and conducted in person at the conference venue: Bellagio Resort & Hotel in Las Vegas, NV. The Planet MicroCap Las Vegas 2026 investor conference website is available here: HOME PAGE.
About Aytu BioPharma
Aytu is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. The Company's prescription products include EXXUA™ (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD), and treatments for attention deficit-hyperactivity disorder (ADHD). Aytu is committed to delivering the Company's medications through best-in-class patient access programs that help to enable optimal patient outcomes. For more information, please visit aytubio.com or follow us on LinkedIn.
Contacts for Investors
Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
[email protected]
Robert Blum
Lytham Partners
[email protected]
SOURCE: Aytu BioPharma, Inc.
View the original press release on ACCESS Newswire
P.Mathewson--AMWN